<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03013595</url>
  </required_header>
  <id_info>
    <org_study_id>REC15/WM/0052</org_study_id>
    <secondary_id>ISRCTN83240263</secondary_id>
    <nct_id>NCT03013595</nct_id>
  </id_info>
  <brief_title>The MILESTONE Study: Improving Transition From Child to Adult Mental Health Care</brief_title>
  <acronym>MILESTONE</acronym>
  <official_title>The Effectiveness of Managed Transition in Improving the Health and Social Outcomes for Young People Transitioning From Child to Adult Mental Health Care: the MILESTONE Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Warwick</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Union</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>IRCCS Centro San Giovanni di Dio Fatebenefratelli</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>King's College London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Yulius</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Ulm</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Katholieke Universiteit Leuven</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University College Dublin</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Clinical Hospital Center, Split</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>HealthTracker Ltd, UK</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Erasmus Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Concentris research management gmbh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Warwick</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the longitudinal health and social outcomes of adolescent mental health
      service users who are at the transition boundary of their child and adolescent mental health
      service, and whether the implementation of a model of managed transition at the service
      boundary benefits them, as compared to usual care.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The MILESTONE study focuses on the period when young people attending a children and
      adolescents mental health service (CAMHS) need to move on, or &quot;transition&quot;, to an adult
      mental health service (AMHS), if they still require care or treatment. We know from other
      research that this transition is not always properly managed and that improving the
      transition process can have a positive impact on the health and well-being of young people in
      this position. We want to evaluate what impact the different transition experiences have on
      young people's health and well-being, and whether the process of Managed Transition has any
      benefits as compared to usual care.

      The MILESTONE study is run in eight European countries (UK, Ireland, Belgium, Holland,
      France, Germany, Italy and Croatia). CAMHS in the study regions are selected to provide the
      young people in their care that are reaching transition age either usual care or a novel
      service called &quot;Managed Transition&quot;, which includes the use of a new decision support tool,
      the Transition Readiness and Appropriateness Measure (TRAM). This should help with decision
      making and enable better transitions by identifying cases for whom transition from CAMHS to
      AMHS is advisable and appropriate, or who can be safely discharged or referred to a community
      based service. CAMHS are randomly assigned to provide the intervention of Managed Transition
      or usual care. The health and well-being of the young people attending these services is
      assessed at the start of the study and then followed-up for 24 months to see whether they
      transition to AMHS or are discharged or referred to some other service.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Actual">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mental health status (need for care) as measured by Health of the Nation Outcome Scale for Children and Adolescents (HoNOSCA - clinician version) at 15 months</measure>
    <time_frame>15 months</time_frame>
    <description>The measure will be completed by a trained MILESTONE research assistant taking into account all available sources of information (including the young person, parent/carer, relevant clinician and the medical records) to ensure accuracy of data.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Self-rated (i.e. completed by young person) mental health status (need for care) on Health of the Nation Outcome Scale for Children and Adolescents (HONOSCA)</measure>
    <time_frame>Baseline, 9, 15, and 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transition outcome assessed by the Transition Related Outcome Measure (TROM) questionnaire</measure>
    <time_frame>Baseline, 9, 15, and 24 months</time_frame>
    <description>The TROM is a questionnaire completed by the young person, parent/carer and clinician</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Emotional and behavioural problems assessed by the Achenbach System of Empirically Based Assessment (ASEBA) Youth Self Report (YSR)/Adult Self Report (ASR) questionnaires (young person)</measure>
    <time_frame>Baseline, 9, 15, and 24 months</time_frame>
    <description>YSR is completed by young people aged 17 years or less; ASR by those 18 years or over</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Emotional and behavioural problems assessed by the Achenbach System of Empirically Based Assessment (ASEBA) Child Behavior Checklist (CBCL) or Adult Behavior Checklist (ABCL) questionnaires (parent/carer)</measure>
    <time_frame>Baseline, 9, 15, and 24 months</time_frame>
    <description>Parent/carer completes CBCL if young person is 17 years or less; ABCL if young person is 18 years or over</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Illness severity assessed by Clinical Global Impression Severity (CGIS) scale (CGIseverity)</measure>
    <time_frame>Baseline, 9, 15, and 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life assessed by World Health Organisation Quality of Life Assessment (WHOQOLBREF)</measure>
    <time_frame>Baseline, 15, and 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Independent behaviour assessed by Independent Behaviour During Consultation Scale (IBDCS)</measure>
    <time_frame>Baseline, 9, 15, and 24 months, if young person is a current service user</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Illness perception assessed by the Brief Illness Perception Questionnaire (BIPQ)</measure>
    <time_frame>Baseline and 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Barriers to care assessed by Barriers to Care (BtC) checklist</measure>
    <time_frame>9, 15, and 24 months, if young person is no longer a service user</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transition experience and readiness assessed by On Your Own Feet - Transition Experience Scale (OYOF-TES)</measure>
    <time_frame>at 9, 15 or 24 months, completed only once at the first assessment after transition</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adult functioning assessed by Specific Levels of Functioning Scale (SLOF)</measure>
    <time_frame>Baseline and 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality Adjusted Life Years (QALYs) assessed by EuroQol generic quality of life questionnaire (EQ-5D-5L)</measure>
    <time_frame>Baseline, 9, 15, and 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Service use assessed by a MILESTONE specific Client Service Receipt Inventory (CSRI)</measure>
    <time_frame>Baseline, 9, 15, and 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mental health status as measured by Health of the Nation Outcome Scale for Children and Adolescents (HoNOSCA - clinician version)</measure>
    <time_frame>Baseline, 9 months, 24 months</time_frame>
    <description>The measure will be completed by a trained MILESTONE research assistant taking into account all available sources of information (including the young person, parent/carer, relevant clinician and the medical records) to ensure accuracy of data.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Mental Health Impairment</condition>
  <condition>Mental Health Disorder</condition>
  <arm_group>
    <arm_group_label>TRAM feedback</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The completion of the &quot;Transition Readiness and Appropriateness Measure&quot; (TRAM, a standardized structured assessment ) prior to the transition boundary by the child and adolescent mental health service (CAMHS) clinician, young person and parent/carer.
Feedback of TRAM findings to the CAMHS clinician to support decisions made regarding transition, communication with stakeholders and the transition process. Clinicians will be expected to communicate the findings to the young person and parent/carer, and, if a referral is made, to send the TRAM feedback to the adult clinician along with the referral letter.
The clinicians will also receive information prior to recruitment begin on the use of TRAM and the way in which it fits in with optimal transition.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients, parent/carers and clinicians in the control arm will complete the TRAM prior to the transition boundary, but the clinicians won't receive any feedback from it nor any information on the benefits of using the decision support tool.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>TRAM feedback</intervention_name>
    <arm_group_label>TRAM feedback</arm_group_label>
    <other_name>Managed transition</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Young person inclusion:

               1. Provides valid written informed consent, or assent, if below the legal age of
                  consent

               2. If age is within one year of reaching the transition boundary of their CAMHS
                  during the trial recruitment period, and, in exceptional cases, not more than 3
                  months older than the transition boundary, if a decision about transition has not
                  yet been made

               3. Has a mental disorder defined by DSM-IV-TR, DSM-5 or ICD 10/11, or is under the
                  regular care of CAMHS (if not yet diagnosed)

               4. Has an IQ â‰¥ 70 as ascertained by previous standardised assessment or diagnosed by
                  clinician, or no indication of intellectual impairment

        Exclusion Criteria:

          -  1. Does not provide valid written informed consent, or assent, if below the legal age
             of consent 2. Is younger than a year before the transition boundary of their CAMHS 3.
             Has intellectual impairment (IQ &lt;70) as ascertained by previous standardised
             assessment or diagnosed by clinician (if no data on intellectual functioning are
             available [because it has never been assessed] then care coordinators will be asked to
             make a clinical judgement on intellectual impairment before baseline assessment takes
             place) 4. If not able to (or expected not to be able to) complete the questionnaires
             due to severe physical disabilities or language problems, even with assistance from
             family members or research assistant 5. Service user in a secure forensic institution
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Swaran P Singh, MD, DM</last_name>
    <role>Principal Investigator</role>
    <affiliation>Warwick Medical School, University of Warwick, UK</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Katholieke Universiteit Leuven</name>
      <address>
        <city>Leuven</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Split</name>
      <address>
        <city>Split</city>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU Montpellier-St Eloi hospital</name>
      <address>
        <city>Montpellier</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Ulm</name>
      <address>
        <city>Ulm</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University College Dublin</name>
      <address>
        <city>Dublin</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IRCCS Fatebenefratelli</name>
      <address>
        <city>Brescia</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yulius Academy</name>
      <address>
        <city>Barendrecht</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Erasmus Medical Centre</name>
      <address>
        <city>Rotterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Warwick Medical School, University of Warwick</name>
      <address>
        <city>Coventry</city>
        <zip>CV4 7AL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>King's College London</name>
      <address>
        <city>London</city>
        <zip>SE5 8AF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Croatia</country>
    <country>France</country>
    <country>Germany</country>
    <country>Ireland</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 28, 2016</study_first_submitted>
  <study_first_submitted_qc>January 5, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 6, 2017</study_first_posted>
  <last_update_submitted>November 15, 2017</last_update_submitted>
  <last_update_submitted_qc>November 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Warwick</investigator_affiliation>
    <investigator_full_name>Swaran Singh</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Mental health</keyword>
  <keyword>Youth mental health</keyword>
  <keyword>Adolescent</keyword>
  <keyword>Health services</keyword>
  <keyword>Transition</keyword>
  <keyword>Longitudinal cohort study</keyword>
  <keyword>Cluster randomised controlled trial</keyword>
  <keyword>Young adult</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mental Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

